[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368036-105":59,"doc-detail-368036-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeted-methylation-of-cg24067911-suppresses-colorectal-cancer-metastasis-through-bcl6-atxn1-cdh1-axis","Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis","","DNA methylation plays a crucial role in colorectal cancer (CRC) progression and metastasis, yet locus-specific mechanisms have remained insufficiently understood. The study identified cg24067911 hypomethylation as a biomarker linked to poor CRC prognosis. Using a CRISPR-dCas9-DNMT3a system, the work selectively altered cg24067911 methylation, then applied transposase-accessible chromatin sequencing, RNA sequencing, and chromatin immunoprecipitation. Hypomethylation enhanced BCL6 binding at an ATXN1 enhancer, increased ATXN1 transcription, and promoted CDH2-mediated epithelial-mesenchymal transition to facilitate metastasis, highlighting prognostic value and therapeutic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeted-methylation-of-cg24067911-suppresses-colorectal-cancer-metastasis-through-bcl6-atxn1-cdh1-axis/368036/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeted-methylation-of-cg24067911-suppresses-colorectal-cancer-metastasis-through-bcl6-atxn1-cdh1-axis/368036.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main target of methylation investigated in this study?","Question",{"text":112,"@type":113},"The study focuses on the CpG site cg24067911 and examines how its methylation status affects colorectal cancer metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was cg24067911 methylation specifically modified?",{"text":117,"@type":113},"Researchers used a CRISPR-dCas9-DNMT3a system to selectively change the methylation status at cg24067911.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway links cg24067911 methylation to CRC metastasis?",{"text":121,"@type":113},"Hypomethylation improves BCL6 binding to an ATXN1 enhancer, upregulates ATXN1 transcription, and promotes CDH2-driven epithelial-mesenchymal transition, facilitating metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368036,1790710896,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Oncogene [www.nature.com/onc](www.nature.com/onc)  \nARTICLE OPEN   \nTargeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis  \nLu-Ping Yang1,2,5, Jia-Qian Huang 1,2,3,5, Chiu-Wing Yeung 1,2,5, Qi-Hua Zhang 1,2,5, Xiao-Li Wei 1,2,5, Qi-Nian Wu1,2, Zi-Xin Qin 1,2,  \nYa-Shang Zheng 1,2, Yu-Hong Xu1,2, Meng Yang 1,2, Kai-Ying Zhang1,2, Zhi-Jun Zuo1,2, Zhen-Yong Quan4, Lang Zhao4, Dong-Yang He4, Jia Liu1,2 ✉, Rui-Hua Xu 1,2 ✉ and Hui-Yan Luo 1,2 ✉  \n© The Author(s) 2025  \n\n| | DNA methylation plays a crucial role in the progression and metastasis of colorectal cancer (CRC), yet the mechanisms underlying its effect at speciﬁc loci remain poorly understood. We previously identiﬁed cg24067911 hypomethylation as a potential biomarker associated with poor CRC prognosis. To investigate the role of cg24067911 methylation in CRC metastasis and elucidate its underlying molecular mechanisms, we utilized the CRISPR-dCas9-DNMT3a system to speciﬁcally modify the methylation status ofcg24067911 . Then, we performed high-throughput transposase-accessible chromatin sequencing, RNA sequencing, and chromatin immunoprecipitation analysis. We demonstrated that cg24067911 was located within an enhancer region of the ATXN1 gene, where it was bound by BCL6 . Hypomethylation of cg24067911 improved the binding of BCL6 to this enhancer, leading to upregulated transcription of ATXN1 . Furthermore, ATXN1 was found to act as a transcription factor that upregulates CDH2, promoting epithelial-mesenchymal transition and facilitating CRC metastasis. These ﬁndings not only reveal that cg24067911 methylation modulates CRC metastasis through a novel epigenetic mechanism involving ATXN1 and CDH2, but also highlight cg24067911 as a potential prognostic marker for CRC and suggest that targeted epigenetic therapies could be an effective strategy for treating CRC metastasis in the future.\u003Cbr>Oncogene (2026) 45:295–306; [https://doi.org/10.1038/s41388-025-03638-z](https://doi.org/10.1038/s41388-025-03638-z) | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \n1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. 2Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, China. 3Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China. 4Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. 5These authors contributed equally: Lu-Ping  \nYang, Jia-Qian Huang, Chiu-Wing Yeung, Qi-Hua Zhang, Xiao-Li Wei. ✉ email: [liujia1@sysucc.org.cn](liujia1@sysucc.org.cn); [xurh@sysucc.org.cn](xurh@sysucc.org.cn); [luohy@sysucc.org.cn](luohy@sysucc.org.cn)  \nReceived: 8 January 2025 Revised: 14 October 2025 Accepted: 12 November 2025  \nPublished online: 2 December 2025  \nL.-P. Yang et al.  \n296  \nINTRODUCTION  \nColorectal cancer (CRC) is the third most common cancer worldwide which has an increasing trend in morbidity and mortality [1] . About 20% of CRC patients present with metastatic disease at diagnosis. For patients receiving curative treatment, 25% of them would ﬁnally experience metastasis [2] . Efforts have been made to enhance accuracy in predicting the prognosis of CRC and metastasis [3, 4] . Metastatic CRC is associated with poor prognosis and limited treatment options, therefore highlighting the importance of understanding the mechanisms underlying metastasis for developing effective therapeutic strategies. Although the mechanism of CRC metastasis has been investigated for several decades in areas such as g","cbCaikpZNaV8On98","https://ap.wps.com/l/cbCaikpZNaV8On98","pdf",11145607,12,"English","# Introduction\n## Background on CRC metastasis and methylation\n## Epigenetic regulation and DNA methylation biomarkers\n## CRISPR-based tools for locus-specific methylation editing","[{\"question\":\"What is the main target of methylation investigated in this study?\",\"answer\":\"The study focuses on the CpG site cg24067911 and examines how its methylation status affects colorectal cancer metastasis.\"},{\"question\":\"How was cg24067911 methylation specifically modified?\",\"answer\":\"Researchers used a CRISPR-dCas9-DNMT3a system to selectively change the methylation status at cg24067911.\"},{\"question\":\"What molecular pathway links cg24067911 methylation to CRC metastasis?\",\"answer\":\"Hypomethylation improves BCL6 binding to an ATXN1 enhancer, upregulates ATXN1 transcription, and promotes CDH2-driven epithelial-mesenchymal transition, facilitating metastasis.\"}]","Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis | PDF",1790174538,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7da252189718cefa3024bbef4a85ce8e.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f42c48d8770a0bd99acde19335749bfa.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f3f272baa8ac51fcc9a799a4620c396.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be513e2e6821ecbc65246240ca371381.webp",980,1301]